• 21 Oct, 2021

Tallac SITC 2021 Presentation

• 15 Apr, 2021

Tallac Therapeutics Appoints Curtis Hecht as Chief Business Officer

• 12 Apr, 2021

Tallac AACR 2021 Presentation

• 12 Mar, 2021

AACR 2021 presentation on preclinical data for TAC-001

• 4 Mar, 2021

ALX Oncology and Tallac Therapeutics Announce Collaboration on Novel Class of Cancer Immunotherapeutics